1 | day | 39,459 |
2 | pod | 607 |
3 | pow | 21 |
4 | dol | 19 |
5 | cycloergometer | 15 |
6 | wup | 14 |
7 | clarity-timi | 10 |
8 | s+c/t | 7 |
9 | p49 | 6 |
10 | pod7 | 6 |
11 | 15minutes | 5 |
12 | 1g/l | 5 |
13 | asaes | 5 |
14 | discharge/day | 4 |
15 | metallicum | 4 |
16 | pi3kr1 | 4 |
17 | ~day | 4 |
18 | β-irradiation | 4 |
19 | 10-µg/m | 3 |
20 | btas | 3 |
21 | current-oasis | 3 |
22 | d114 | 3 |
23 | disrupted-in-schizophrenia | 3 |
24 | open/standard | 3 |
25 | printex | 3 |
26 | taqat | 3 |
27 | torecan | 3 |
28 | 20/10/2005 | 2 |
29 | 320-mdct | 2 |
30 | 5°f | 2 |
31 | 70kg | 2 |
32 | c-13 | 2 |
33 | frsbe-total | 2 |
34 | hospitalization/at | 2 |
35 | icu-day | 2 |
36 | ipss-question | 2 |
37 | ldl-levels | 2 |
38 | mirtazipine | 2 |
39 | movement/mobilisation | 2 |
40 | snap-freezing | 2 |
41 | work-day | 2 |
42 | z-testing | 2 |
43 | 'quitter | 1 |
44 | 0-50- | 1 |
45 | 107-bp | 1 |
46 | 11.047 | 1 |
47 | 118-bp | 1 |
48 | 15/02/2013 | 1 |
49 | 17-minute | 1 |
50 | 2/post-dose | 1 |
51 | 3/hour | 1 |
52 | 41type | 1 |
53 | 58-bp | 1 |
54 | 60,00 | 1 |
55 | aculus | 1 |
56 | admission.only | 1 |
57 | antiinterleukin | 1 |
58 | ape1-catalyzed | 1 |
59 | asa-withdrawal | 1 |
60 | chirallica | 1 |
61 | commodore | 1 |
62 | days-and | 1 |
63 | death.at | 1 |
64 | dimethylcarboxamides | 1 |
65 | double-breath | 1 |
66 | er-membrane | 1 |
67 | europerio | 1 |
68 | exmination | 1 |
69 | feed-associated | 1 |
70 | femminello | 1 |
71 | ffpe-pre-treatment | 1 |
72 | first-in-phase | 1 |
73 | fluticasone/salmeterol.secondary | 1 |
74 | gavaging | 1 |
75 | hb-band | 1 |
76 | hf/dialysis | 1 |
77 | increase- | 1 |
78 | inhibitor-phenethyl | 1 |
79 | jarabe | 1 |
80 | jcn | 1 |
81 | little-if | 1 |
82 | marked-out | 1 |
83 | non-lacquer | 1 |
84 | nongenotype | 1 |
85 | oahi≤ | 1 |
86 | ocober | 1 |
87 | pain.only | 1 |
88 | patinopecten | 1 |
89 | peppermint-flavored | 1 |
90 | physican | 1 |
91 | scarites | 1 |
92 | tax-based | 1 |
1 | 'quitter | 1 |
2 | 0-50- | 1 |
3 | 10-µg/m | 3 |
4 | 107-bp | 1 |
5 | 11.047 | 1 |
6 | 118-bp | 1 |
7 | 15/02/2013 | 1 |
8 | 15minutes | 5 |
9 | 17-minute | 1 |
10 | 1g/l | 5 |
11 | 2/post-dose | 1 |
12 | 20/10/2005 | 2 |
13 | 3/hour | 1 |
14 | 320-mdct | 2 |
15 | 41type | 1 |
16 | 58-bp | 1 |
17 | 5°f | 2 |
18 | 60,00 | 1 |
19 | 70kg | 2 |
20 | aculus | 1 |
21 | admission.only | 1 |
22 | antiinterleukin | 1 |
23 | ape1-catalyzed | 1 |
24 | asa-withdrawal | 1 |
25 | asaes | 5 |
26 | btas | 3 |
27 | c-13 | 2 |
28 | chirallica | 1 |
29 | clarity-timi | 10 |
30 | commodore | 1 |
31 | current-oasis | 3 |
32 | cycloergometer | 15 |
33 | d114 | 3 |
34 | day | 39,459 |
35 | days-and | 1 |
36 | death.at | 1 |
37 | dimethylcarboxamides | 1 |
38 | discharge/day | 4 |
39 | disrupted-in-schizophrenia | 3 |
40 | dol | 19 |
41 | double-breath | 1 |
42 | er-membrane | 1 |
43 | europerio | 1 |
44 | exmination | 1 |
45 | feed-associated | 1 |
46 | femminello | 1 |
47 | ffpe-pre-treatment | 1 |
48 | first-in-phase | 1 |
49 | fluticasone/salmeterol.secondary | 1 |
50 | frsbe-total | 2 |
51 | gavaging | 1 |
52 | hb-band | 1 |
53 | hf/dialysis | 1 |
54 | hospitalization/at | 2 |
55 | icu-day | 2 |
56 | increase- | 1 |
57 | inhibitor-phenethyl | 1 |
58 | ipss-question | 2 |
59 | jarabe | 1 |
60 | jcn | 1 |
61 | ldl-levels | 2 |
62 | little-if | 1 |
63 | marked-out | 1 |
64 | metallicum | 4 |
65 | mirtazipine | 2 |
66 | movement/mobilisation | 2 |
67 | non-lacquer | 1 |
68 | nongenotype | 1 |
69 | oahi≤ | 1 |
70 | ocober | 1 |
71 | open/standard | 3 |
72 | p49 | 6 |
73 | pain.only | 1 |
74 | patinopecten | 1 |
75 | peppermint-flavored | 1 |
76 | physican | 1 |
77 | pi3kr1 | 4 |
78 | pod | 607 |
79 | pod7 | 6 |
80 | pow | 21 |
81 | printex | 3 |
82 | s+c/t | 7 |
83 | scarites | 1 |
84 | snap-freezing | 2 |
85 | taqat | 3 |
86 | tax-based | 1 |
87 | torecan | 3 |
88 | work-day | 2 |
89 | wup | 14 |
90 | z-testing | 2 |
91 | ~day | 4 |
92 | β-irradiation | 4 |
1 | 0-50- | 1 |
2 | increase- | 1 |
3 | 60,00 | 1 |
4 | pi3kr1 | 4 |
5 | c-13 | 2 |
6 | 15/02/2013 | 1 |
7 | d114 | 3 |
8 | 20/10/2005 | 2 |
9 | 11.047 | 1 |
10 | pod7 | 6 |
11 | p49 | 6 |
12 | chirallica | 1 |
13 | disrupted-in-schizophrenia | 3 |
14 | peppermint-flavored | 1 |
15 | tax-based | 1 |
16 | feed-associated | 1 |
17 | ape1-catalyzed | 1 |
18 | days-and | 1 |
19 | hb-band | 1 |
20 | pod | 607 |
21 | open/standard | 3 |
22 | jarabe | 1 |
23 | er-membrane | 1 |
24 | mirtazipine | 2 |
25 | 41type | 1 |
26 | nongenotype | 1 |
27 | commodore | 1 |
28 | first-in-phase | 1 |
29 | 2/post-dose | 1 |
30 | 17-minute | 1 |
31 | little-if | 1 |
32 | 5°f | 2 |
33 | 70kg | 2 |
34 | gavaging | 1 |
35 | z-testing | 2 |
36 | snap-freezing | 2 |
37 | double-breath | 1 |
38 | clarity-timi | 10 |
39 | 1g/l | 5 |
40 | frsbe-total | 2 |
41 | asa-withdrawal | 1 |
42 | dol | 19 |
43 | inhibitor-phenethyl | 1 |
44 | 10-µg/m | 3 |
45 | metallicum | 4 |
46 | torecan | 3 |
47 | physican | 1 |
48 | jcn | 1 |
49 | patinopecten | 1 |
50 | antiinterleukin | 1 |
51 | β-irradiation | 4 |
52 | exmination | 1 |
53 | movement/mobilisation | 2 |
54 | ipss-question | 2 |
55 | europerio | 1 |
56 | femminello | 1 |
57 | 107-bp | 1 |
58 | 118-bp | 1 |
59 | 58-bp | 1 |
60 | wup | 14 |
61 | ocober | 1 |
62 | cycloergometer | 15 |
63 | 'quitter | 1 |
64 | non-lacquer | 1 |
65 | 3/hour | 1 |
66 | btas | 3 |
67 | asaes | 5 |
68 | dimethylcarboxamides | 1 |
69 | scarites | 1 |
70 | 15minutes | 5 |
71 | current-oasis | 3 |
72 | hf/dialysis | 1 |
73 | ldl-levels | 2 |
74 | aculus | 1 |
75 | s+c/t | 7 |
76 | death.at | 1 |
77 | hospitalization/at | 2 |
78 | taqat | 3 |
79 | 320-mdct | 2 |
80 | ffpe-pre-treatment | 1 |
81 | marked-out | 1 |
82 | pow | 21 |
83 | printex | 3 |
84 | day | 39,459 |
85 | work-day | 2 |
86 | icu-day | 2 |
87 | discharge/day | 4 |
88 | ~day | 4 |
89 | pain.only | 1 |
90 | admission.only | 1 |
91 | fluticasone/salmeterol.secondary | 1 |
92 | oahi≤ | 1 |